Ftse Mib
34.520,65
0,71%
DAX
18.575,94
0,86%
S&P 500
5.332,98
0,79%
NASDAQ
17.083,79
1,35%
Bitcoin
71.499,91
1,24%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cancer Genetics Inc (CGIX) Cancer Genetics Inc (CGIX) Notizie

CGIX

Cancer Genetics (CGIX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CGIX
DataOraFonteTitoloSimboloCompagnia
15/05/202314:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CGIXCancer Genetics Inc
10/05/202314:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CGIXCancer Genetics Inc
04/05/202322:33Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:CGIXCancer Genetics Inc
28/03/202312:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CGIXCancer Genetics Inc
24/03/202314:05Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CGIXCancer Genetics Inc
24/03/202313:35Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CGIXCancer Genetics Inc
19/01/202322:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CGIXCancer Genetics Inc
14/11/202222:46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CGIXCancer Genetics Inc
15/08/202214:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:CGIXCancer Genetics Inc
14/06/202222:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CGIXCancer Genetics Inc
03/06/202222:06Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CGIXCancer Genetics Inc
12/05/202215:13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:CGIXCancer Genetics Inc
29/04/202223:46Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:CGIXCancer Genetics Inc
11/04/202212:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CGIXCancer Genetics Inc
30/03/202213:39Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CGIXCancer Genetics Inc
14/02/202219:04Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CGIXCancer Genetics Inc
11/02/202213:37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CGIXCancer Genetics Inc
29/12/202122:31Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CGIXCancer Genetics Inc
18/05/202112:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CGIXCancer Genetics Inc
02/04/202101:02Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CGIXCancer Genetics Inc
31/03/202112:30GlobeNewswire Inc.Cancer Genetics and StemoniX Announce Merger ClosingNASDAQ:CGIXCancer Genetics Inc
25/03/202114:16Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CGIXCancer Genetics Inc
25/03/202114:15GlobeNewswire Inc.Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniXNASDAQ:CGIXCancer Genetics Inc
18/03/202113:30GlobeNewswire Inc.Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business DevelopmentNASDAQ:CGIXCancer Genetics Inc
12/03/202115:30GlobeNewswire Inc.Cancer Genetics to Present at the Annual 33rd ROTH ConferenceNASDAQ:CGIXCancer Genetics Inc
04/03/202122:15GlobeNewswire Inc.Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences ConferenceNASDAQ:CGIXCancer Genetics Inc
26/02/202122:51Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:CGIXCancer Genetics Inc
16/02/202122:45GlobeNewswire Inc.Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq RulesNASDAQ:CGIXCancer Genetics Inc
11/02/202105:00GlobeNewswire Inc.Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq RulesNASDAQ:CGIXCancer Genetics Inc
08/02/202122:56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CGIXCancer Genetics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CGIX

La tua Cronologia

ASX
ASXKOQ
BIT
P1T7X7
NLBNPIT1T7X7 20240621 2100
TSX
DAY
Ceridian HCM
TSXV
TORO
Pucara Gold
GATE
AEETH
Aeternity
TSXV
OEE
Memex
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network